Previous close | 53.34 |
Open | 53.46 |
Bid | 52.96 x 0 |
Ask | 53.00 x 0 |
Day's range | 52.38 - 53.50 |
52-week range | 40.32 - 58.08 |
Volume | |
Avg. volume | 748,952 |
Market cap | 59.305B |
Beta (5Y monthly) | 0.63 |
PE ratio (TTM) | 38.67 |
EPS (TTM) | 1.37 |
Earnings date | 02 Aug 2023 |
Forward dividend & yield | 0.95 (1.78%) |
Ex-dividend date | 16 Feb 2023 |
1y target est | 58.40 |
CHARLOTTE, N.C. & MALVERN, Pa., November 28, 2022--Siemens Healthineers and Atrium Health, a leading nonprofit health provider known for its top-ranked pediatric, cancer and heart care programs, have announced a multi-year Value Partnership1 agreement. This strategic agreement will focus on driving access to care in Atrium Health’s service region across the southeastern U.S., improving health equity and enhancing economic mobility. Atrium Health will purchase $140 million in Siemens Healthineers
MALVERN, Pa. & MIAMI, October 31, 2022--Siemens Healthineers and UHealth - University of Miami Health System announced a Value Partnership1 agreement. This strategic relationship will further technological advancement and standardization of equipment at the health system, while allowing the University to create educational and training programs for clinicians and technologists. This unique agreement is the first of its kind in Florida.
MALVERN, Pa., June 28, 2022--Siemens Healthineers and The Ohio State University Wexner Medical Center announced a new alliance, aimed at advancing personalized medicine and improving access to high quality, cost-effective healthcare. Through the five-year strategic partnership, Siemens Healthineers and Varian, a Siemens Healthineers company, will provide comprehensive technology and services that will build on previous successful collaborative projects. The university and medical center will con
DGAP-News: Siemens Healthineers AG / Key word(s): Share Buyback/Share BuybackSiemens Healthineers AG: Publication of a capital market information 27.06.2022 / 21:56 The issuer is solely responsible for the content of this announcement.Disclosure pursuant to Art. 5 para. 1 lit. a) of the Regulation (EU) No. 596/2014 (MAR) in conjunction with Art. 2 para. 1 of the Delegated Regulation (EU) No. 2016/1052The share buyback resolved on 24 June 2022 by the Managing Board of Siemens Healthineers AG (her